ESTRO 2024 - Abstract Book

S1777

Clinical - Lung

ESTRO 2024

[3] Normal Ranges of Left Ventricular Strain: A Meta-Analysis. T. Yingchoncharoen et al., Journal of the American Society of Echocardiography 2013; 26, Issue 2, 185-191

2744

Digital Poster

Advances in Stereotactic Body Radiation Therapy for recurrent thymoma: a monocentric experience

Chiara Paronetto 1 , Matteo Sepulcri 1 , Francesca Gessoni 2 , Francesca Dusi 3 , Giulia Pasello 4,5 , Giovanni Maria Comacchio 6 , Marta Paiusco 3 , Valentina Guarneri 4,5 , Federico Rea 6 , Marco Krengli 1,5 1 Veneto Institute of Oncology IOV-IRCCS, Radiotherapy, Padova, Italy. 2 University of Padova, Medicine and Surgery, Padova, Italy. 3 Veneto Institute of Oncology IOV-IRCCS, Medical Physics, Padova, Italy. 4 Veneto Institute of Oncology IOV-IRCCS, Medical Oncology 2, Padova, Italy. 5 University of Padova, Department of Surgery, Oncology and Gastroenterology, Padova, Italy. 6 University Hospital of Padova, Department of Cardiac, Thoracic, Vascular sciences and Public Health, Padova, Italy

Purpose/Objective:

Recurrent thymoma is a challenging clinical entity characterized by limited research on optimal treatment strategies. Despite aggressive surgical interventions, recurrence rates remain substantial, ranging from 10% to 30%. Thymomas often metastasize to the pleura and lungs, adding complexity to the management of this condition. The advent of stereotactic body radiation therapy (SBRT) has emerged as a promising approach, providing an opportunity to deliver radiation treatments with radical intent in carefully selected patients. Our institution previously conducted a study to explore the efficacy of SBRT in treating patients with oligorecurrent thymoma, demonstrating favorable results in terms of local disease control (LC) and limited toxicities. This report describes the experience of our center, with an extended follow-up period.

Material/Methods: